IFIsaque da Silva Ferreira

Isaque da Silva Ferreira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Isaque da Silva Ferreira has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Cecília da Silva Ferreira

    Universidade de São Paulo, Brazil

    3 shared publications
  • José Maria Soares Júnior

    Laboratório de Ginecologia Estrutural e Molecular (LIM-58), Disciplina de Ginecologia, Departamento de Obstetrícia e Ginecologia, Hospital das Clínicas HC-FMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo 05403-010, Brazil

    3 shared publications
  • Edmund Chada Baracat

    Laboratório de Ginecologia Estrutural e Molecular (LIM 58), Disciplina de Ginecologia, Departamento de Obstetrícia e Ginecologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil

    2 shared publications
  • José Cipolla-Neto

    Laboratório de Neurobiologia, Departamento de Fisiologia e Biofísica Instituto de Ciências Biomédicas, Universidade de São Paulo São Paulo Brazil

    2 shared publications
  • Ana P. R. Paiotti

    Laboratory of Pathology Molecular, Departamento de Patologia, Universidade Federal de São Paulo, São Paulo, Brazil

    1 shared publication
  • Carla C. Maganhin

    Laboratory of Structural and Molecular Gynecology (LIM-58), Disciplina de Ginecologia - Departmento de Ginecologia e Obstetrícia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

    1 shared publication

Latest Publications

  • Open Access

    Melatonin's oncostatic effects in experimental breast cancer: A systematic review of dose-response and apoptotic mechanisms in animal models

    by Mayara Souza Alves, Luciana Lamarão Damous, Isaque da Silva Ferreira, Cecília da Silva Ferreira, Isabel Cristina Esposito Sorpreso, José Cipolla-Neto, Edmund Chada Baracat, José Maria Soares


  • Open Access

    Affective temperament and emotion regulation as predictors of clinical outcomes in women with idiopathic granulomatous mastitis

    by Cagri Akalın, Ilker Sengul, Demet Sengul, Halil Ibrahim Tas, Gabriela Bezerra Nóbrega, Cecília da Silva Ferreira, Isaque da Silva Ferreira, José Maria Soares Junior

    SUMMARY OBJECTIVE: The aim of this study was to evaluate affective temperament, emotion regulation, and anxiety–depression symptoms in women with idiopathic granulomatous mastitis, and to determine whether these psychological factors predict clinically relevant outcomes. METHODS: This case–control study included 97 patients with idiopathic granulomatous mastitis and 100 healthy controls. Affective temperament, emotion regulation, and anxiety–depression symptoms were assessed using the Temperament Evaluation of Memphis, Pisa, Paris, and San Diego Autoquestionnaire, the Difficulties in Emotion Regulation Scale, and the Hospital Anxiety and Depression Scale, respectively. Multivariable logistic regression analyses had been performed to identify psychological predictors of recurrence, treatment resistance, and fistula formation. RESULTS: Between-group analyses showed higher depressive and anxious temperament traits in women with idiopathic granulomatous mastitis, greater emotion regulation difficulties, and elevated anxiety–depression symptoms (all p<0.001). Emotion regulation impairment independently predicted treatment resistance (OR 2.86, p=0.004). In contrast, anxious temperament was inversely associated with both recurrence (OR 0.33, p=0.012) and treatment resistance (OR 0.35, p=0.010). No psychological variable predicted fistula formation. CONCLUSION: Idiopathic granulomatous mastitis is associated with a distinct psychosomatic vulnerability profile. While impaired emotion regulation increases the risk of refractory disease, anxious temperament may be linked to protective vigilance-related behaviors. These findings support the integration of psychoneuroimmunology-informed psychological assessment into idiopathic granulomatous mastitis management.

  • Open Access

    The influence of two neurohormones on breast cancer: prolactin and melatonin

    by Cecília da Silva Ferreira, Kátia Cândido Carvalho, Isaque da Silva Ferreira, Giovanna Santos Cavalcanti, José Cipolla Neto, Pedro Egydio Oliveira Zambotti, Edmund Chada Baracat, José Maria Soares Junior

    The influence of prolactin (PRL) and melatonin on breast cancer represents a complex interplay of hormonal signaling with significant implications for tumor progression and therapeutic strategies. PRL, a polypeptide hormone produced primarily by the pituitary gland but also locally in mammary tissue, plays a dual role in breast physiology and pathology1. It acts synergistically with estrogen and progesterone to promote proliferation and differentiation of mammary epithelial cells, processes that are essential for lactation1,2. However, its involvement in breast cancer remains debated, with most studies suggesting proliferative and pro-metastatic effects. PRL exerts its actions through specific transmembrane receptors (prolactin receptor [PRLR])1,2, activating signaling pathways such as JAK2/STAT5, Ras/MAPK, and PI3K/AKT, which drive cell survival, proliferation, and differentiation. Controversially, while PRL overexpression in cell culture enhances tumor growth, PRLR knockdown or antagonism can lead to more aggressive but less differentiated tumors, highlighting the context-dependent nature of PRL's role in breast cancer. Therefore, blood PRL concentration is important for the development of cancer1-4.

  • Does melatonin influence the apoptosis in rat uterus of animals exposed to continuous light?

    by Cecília S. Ferreira, Kátia C. Carvalho, Carla C. Maganhin, Ana P. R. Paiotti, Celina T. F. Oshima, Manuel J. Simões, Edmund C. Baracat, José M. Soares

    Melatonin has been described as a protective agent against cell death and oxidative stress in different tissues, including in the reproductive system. However, the information on the action of this hormone in rat uterine apoptosis is low. Our objective was to evaluate the effects of melatonin on mechanisms of cell death in uterus of rats exposed to continuous light stress. Twenty adult Wistar rats were divided into two groups: GContr (vehicle control) and GExp which were treated with melatonin (0.4 mg/mL), both were exposed to continuous light for 90 days. The uterus was removed and processed for quantitative real time PCR (qRT-PCR), using PCR-array plates of the apoptosis pathway; for immunohistochemistry and TUNEL. The results of qRT-PCR of GEXP group showed up-regulation of 13 and 7, pro-apoptotic and anti-apoptotic genes, respectively, compared to GContr group. No difference in pro-apoptotic proteins (Bax, Fas and Faslg) expression was observed by immunohistochemistry, although the number of TUNEL-positive cells was lower in the group treated with melatonin compared to the group not treated with this hormone. Our data suggest that melatonin influences the mechanism and decreases the apoptosis in uterus of rats exposed to continuous light.